| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/03/2008 | WO2008077647A2 Alpha- amino alcohols as non-steroidal progesterone receptor modulators |
| 07/03/2008 | WO2008077646A1 Non-steroidal progesterone receptor modulators |
| 07/03/2008 | US20080161309 Novel Compounds |
| 07/03/2008 | US20080161308 e.g. 4-[6-(2-cyclohexylethoxy)-3-oxoindan-5-yloxy]butanoic acid; peroxisome proliferator-activated receptor (PPAR) gamma agonist; antiinflammatory, antidiabetic agent; dyslipidaemia, atherosclerosis, insulin resistance |
| 07/03/2008 | US20080161301 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity |
| 07/03/2008 | US20080161300 Heterobicyclic metalloprotease inhibitors |
| 07/03/2008 | US20080161298 Spiro-piperidine derivatives |
| 07/03/2008 | US20080161290 Serine hydrolase inhibitors |
| 07/03/2008 | US20080160627 Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection |
| 07/03/2008 | CA2673466A1 Substituted tetracycline compounds |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1937708A1 Asymmetric synthesis of peptides |
| 07/02/2008 | EP1937632A1 Novel compounds |
| 07/02/2008 | CN100398154C Remedies for psychoneurosis |
| 07/01/2008 | US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects |
| 06/26/2008 | WO2008076754A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/26/2008 | WO2008075025A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080153802 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein |
| 06/26/2008 | DE102006061913A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula |
| 06/26/2008 | CA2672792A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | CA2672271A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/25/2008 | EP1934169A1 Aldimines comprising reactive groups containing active hydrogen, and use thereof |
| 06/25/2008 | EP1730127B1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/25/2008 | CN101208316A Method for producing betamimetics |
| 06/19/2008 | WO2008073067A1 Novel spiro-quinuclidinyl derivatives for the treatment of the central nervous system disorders |
| 06/19/2008 | WO2008072850A1 Triazine derivatives having inhibitory activity against acetyl-coa carboxylase |
| 06/19/2008 | WO2008052075A3 Benzoxazine derivatives and uses thereof |
| 06/19/2008 | US20080146797 Process for synthesizing heterocyclic compounds |
| 06/19/2008 | US20080146554 Substituted Cycloalkyl Derivatives, Process for the Manufacture thereof and Use thereof as Medicament |
| 06/19/2008 | CA2650329A1 Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors |
| 06/18/2008 | EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/18/2008 | CN100395240C Method for synthesizing (3s-cis)-benzoyl methyl ester-[4-(6-methyl-2,5-diketone-3-morpholinyl)butyl]-amino formic acid |
| 06/17/2008 | US7388006 Non-steroidal progesting |
| 06/17/2008 | CA2369947C Hydroxamic acid derivative |
| 06/17/2008 | CA2286772C Fungicide active substance combinations |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139544 Modulators of CCR5(chemokine) receptors; lymphadenopathy associated and human T-cell leukemia/lymphoma viruses; AIDS infections; autoimmune diseases; antiinflammatory agents; derivatives of 1-oxa-3,8-diaza-spiro[4.5]decan-2-one and 1-oxa-3,9-diaza-spiro[5.5]undecan-2-one |
| 06/12/2008 | US20080139540 Antibacterial Agents |
| 06/12/2008 | US20080139539 6-{[(2-{4-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-1-piperazinyl}ethyl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 06/11/2008 | EP1930326A1 Synthesis of new dihydrobenzoxazine |
| 06/11/2008 | EP1928847A2 Theramutein modulators |
| 06/11/2008 | EP1727809B1 Substituted morpholine and thiomorpholine derivatives |
| 06/11/2008 | CN100393707C Intermediates in process for the industrial synthesis of substitute thiophenecarboxydimethylester |
| 06/10/2008 | US7384982 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/10/2008 | US7384970 Inhibitors of cathepsin S |
| 06/10/2008 | US7384941 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| 06/10/2008 | US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
| 06/05/2008 | WO2008066855A1 Method of preparing benzoxazines |
| 06/05/2008 | WO2008066097A1 Carboxylic acid derivative |
| 06/05/2008 | US20080132499 Platelet adp receptor inhibitors |
| 06/05/2008 | US20080132480 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 06/05/2008 | CA2671080A1 Carboxylic acid derivatives |
| 06/04/2008 | CN100391951C Synthesis method of butadiene morpholine |
| 06/03/2008 | US7381856 Carbon-carbon cross coupling catalyzed by transition metals on solid supports |
| 06/03/2008 | US7381720 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 05/29/2008 | WO2008062740A1 Nitrogenated fused ring compound and use thereof |
| 05/29/2008 | US20080125586 probes, modulators or detectors of the activity of cytochrome P450 monooxygenase enzyme system, used for high throughput drug screenning |
| 05/29/2008 | US20080125430 New small molecule inhibitors of mdm2 and the uses thereof |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080122346 Anthrancene derivative compound and organic light-emitting device including the same |
| 05/29/2008 | CA2667353A1 Oxazolidinium compounds and use as hydrate inhibitors |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | CN101189208A 3-methanesulfonylquinolines as GABA-B enhancers |
| 05/28/2008 | CN100390157C Substituted benzoxazinones and uses thereof |
| 05/27/2008 | US7378521 Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates |
| 05/27/2008 | US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 05/27/2008 | US7378416 3-((C3-8)cycloalkyl)-3,4-dihydro-benzo[e][1,3]oxazin-2-ones; counter-regulator of antiinflammatory effects of glucocorticoids with effect that normal activities of glucocorticoids to limit and suppress severity of inflammatory responses are inhibited by macriphage migration inhibitory factor (MIF) |
| 05/27/2008 | US7378415 Benzoxazine and quinoxaline derivatives and uses thereof |
| 05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 05/22/2008 | WO2008059948A1 Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide |
| 05/22/2008 | WO2008023004A8 Single enantiomer beta agonists method for production and use thereof as a medicament |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923387A1 Acylguanidine derivative or salt thereof |
| 05/21/2008 | CN101184738A Purified form of tanaproget |
| 05/20/2008 | US7375236 producing a morpholine-substituted phenacyl derivative, or a salt thereof, comprise reaction of a specific novel compound with morpholine, reaction of the product with a halogenating reagent, and deketalization of the product |
| 05/20/2008 | US7375133 Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 05/20/2008 | US7375104 Long acting beta-2-agonists and their use as medicaments |
| 05/20/2008 | US7375099 Malonamide derivatives |
| 05/15/2008 | WO2008036843A3 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113974 Heterocyclic Oxime Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them. |
| 05/15/2008 | US20080113341 Fluorinated resorufin compounds and their application |
| 05/14/2008 | EP1919884A1 N-benzyl-morpholine derivatives as modulators of the chemokine receptor |
| 05/14/2008 | CN100387582C N-carboxylic acid derivative substituted benzooxazine compounds with herbicidal activity |
| 05/13/2008 | US7371855 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 05/13/2008 | US7371854 Method for the production of bicyclic aromatic amino acids and intermediate products thereof |
| 05/13/2008 | US7371745 Bis-transition-metal-chelate probes |
| 05/08/2008 | WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108618 Compounds with activity on muscarinic receptors |
| 05/08/2008 | US20080108608 Pyrimidines With Tie2 (Tek) Activity |
| 05/08/2008 | US20080108595 Inhibitors of cathepsin s |
| 05/08/2008 | CA2664430A1 Immunochemically equivalent hiv drug analogs |
| 05/07/2008 | EP1917253A1 Method for producing betamimetics |
| 05/07/2008 | EP1917235A1 Process for preparing enantiomerically enriched beta-amino acid derivatives |
| 05/07/2008 | EP1603880B1 Quinolinone/benzoxazinone derivatives and uses thereof |